- Home
- GIFT vs PYPD Comparison
GIFT vs PYPD Comparison
Compare GIFT & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIFT
- PYPD
- Stock Information
- Founded
- GIFT 1999
- PYPD 2008
- Country
- GIFT United States
- PYPD Israel
- Employees
- GIFT N/A
- PYPD N/A
- Industry
- GIFT Catalog/Specialty Distribution
- PYPD Medical/Dental Instruments
- Sector
- GIFT Consumer Discretionary
- PYPD Health Care
- Exchange
- GIFT Nasdaq
- PYPD Nasdaq
- Market Cap
- GIFT 33.9M
- PYPD 34.8M
- IPO Year
- GIFT N/A
- PYPD 2020
- Fundamental
- Price
- GIFT $1.05
- PYPD $3.37
- Analyst Decision
- GIFT Strong Buy
- PYPD Strong Buy
- Analyst Count
- GIFT 1
- PYPD 5
- Target Price
- GIFT $4.00
- PYPD $12.00
- AVG Volume (30 Days)
- GIFT 21.6K
- PYPD 52.0K
- Earning Date
- GIFT 11-12-2025
- PYPD 11-12-2025
- Dividend Yield
- GIFT N/A
- PYPD N/A
- EPS Growth
- GIFT N/A
- PYPD N/A
- EPS
- GIFT N/A
- PYPD N/A
- Revenue
- GIFT $90,569,384.00
- PYPD N/A
- Revenue This Year
- GIFT $5.90
- PYPD N/A
- Revenue Next Year
- GIFT $13.45
- PYPD N/A
- P/E Ratio
- GIFT N/A
- PYPD N/A
- Revenue Growth
- GIFT 8.55
- PYPD N/A
- 52 Week Low
- GIFT $0.82
- PYPD $2.30
- 52 Week High
- GIFT $3.86
- PYPD $3.93
- Technical
- Relative Strength Index (RSI)
- GIFT 46.62
- PYPD 44.08
- Support Level
- GIFT $1.04
- PYPD $3.35
- Resistance Level
- GIFT $1.14
- PYPD $3.54
- Average True Range (ATR)
- GIFT 0.08
- PYPD 0.12
- MACD
- GIFT 0.00
- PYPD -0.00
- Stochastic Oscillator
- GIFT 18.10
- PYPD 16.67
About GIFT RDE Inc. Common Stock
Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.